Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Terry S. Desser is active.

Publication


Featured researches published by Terry S. Desser.


Cancer | 2009

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

Daniel T. Chang; Devin Schellenberg; John Shen; Jeff Kim; Karyn A. Goodman; George A. Fisher; James M. Ford; Terry S. Desser; Andrew Quon; Albert C. Koong

The authors report on the local control and toxicity of stereotactic body radiotherapy (SBRT) for patients with unresectable pancreatic adenocarcinoma.


International Journal of Radiation Oncology Biology Physics | 2008

Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

Devin Schellenberg; Karyn A. Goodman; Florence Lee; Stephanie T. Chang; T. Kuo; James M. Ford; George A. Fisher; Andrew Quon; Terry S. Desser; Jeffrey A. Norton; Ralph S. Greco; George P. Yang; Albert C. Koong

PURPOSE Fractionated radiotherapy and chemotherapy for locally advanced pancreatic cancer achieves only modest local control. This prospective trial evaluated the efficacy of a single fraction of 25 Gy stereotactic body radiotherapy (SBRT) delivered between Cycle 1 and 2 of gemcitabine chemotherapy. METHODS AND MATERIALS A total of 16 patients with locally advanced, nonmetastatic, pancreatic adenocarcinoma received gemcitabine with SBRT delivered 2 weeks after completion of the first cycle. Gemcitabine was resumed 2 weeks after SBRT and was continued until progression or dose-limiting toxicity. The gross tumor volume, with a 2-3-mm margin, was treated in a single 25-Gy fraction by Cyberknife. Patients were evaluated at 4-6 weeks, 10-12 weeks, and every 3 months after SBRT. RESULTS All 16 patients completed SBRT. A median of four cycles (range one to nine) of chemotherapy was delivered. Three patients (19%) developed local disease progression at 14, 16, and 21 months after SBRT. The median survival was 11.4 months, with 50% of patients alive at 1 year. Patients with normal carbohydrate antigen (CA)19-9 levels either at diagnosis or after Cyberknife SBRT had longer survival (p <0.01). Acute gastrointestinal toxicity was mild, with 2 cases of Grade 2 (13%) and 1 of Grade 3 (6%) toxicity. Late gastrointestinal toxicity was more common, with five ulcers (Grade 2), one duodenal stenosis (Grade 3), and one duodenal perforation (Grade 4). A trend toward increased duodenal volumes radiated was observed in those experiencing late effects (p = 0.13). CONCLUSION SBRT with gemcitabine resulted in comparable survival to conventional chemoradiotherapy and good local control. However, the rate of duodenal ulcer development was significant.


International Journal of Radiation Oncology Biology Physics | 2011

SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER

Devin Schellenberg; Jeff Kim; Claudia Christman-Skieller; Carlene L. Chun; Laurie Ann Columbo; James M. Ford; George A. Fisher; Pamela L. Kunz; Jacques Van Dam; Andrew Quon; Terry S. Desser; Jeffrey A. Norton; A Hsu; Peter G. Maxim; Lei Xing; Karyn A. Goodman; Daniel T. Chang; Albert C. Koong

PURPOSE This Phase II trial evaluated the toxicity, local control, and overall survival in patients treated with sequential gemcitabine and linear accelerator-based single-fraction stereotactic body radiotherapy (SBRT). METHODS AND MATERIALS Twenty patients with locally advanced, nonmetastatic pancreatic adenocarcinoma were enrolled on this prospective single-institution, institutional review board-approved study. Gemcitabine was administered on Days 1, 8, and 15, and SBRT on Day 29. Gemcitabine was restarted on Day 43 and continued for 3-5 cycles. SBRT of 25 Gy in a single fraction was delivered to the internal target volume with a 2- 3-mm margin using a nine-field intensity-modulated radiotherapy technique. Respiratory gating was used to account for breathing motion. Follow-up evaluations occurred at 4-6 weeks, 10-12 weeks, and every 3 months after SBRT. RESULTS All patients completed SBRT and a median of five cycles of chemotherapy. Follow-up for the 2 remaining alive patients was 25.1 and 36.4 months. No acute Grade 3 or greater nonhematologic toxicity was observed. Late Grade 3 or greater toxicities occurred in 1 patient (5%) and consisted of a duodenal perforation (G4). Three patients (15%) developed ulcers (G2) that were medically managed. Overall, median survival was 11.8 months, with 1-year survival of 50% and 2-year survival of 20%. Using serial computed tomography, the freedom from local progression was 94% at 1 year. CONCLUSION Linear accelerator-delivered SBRT with sequential gemcitabine resulted in excellent local control of locally advanced pancreatic cancer. Future studies will address strategies for reducing long-term duodenal toxicity associated with SBRT.


Seminars in Ultrasound Ct and Mri | 2001

Tissue harmonic imaging techniques: Physical principles and clinical applications

Terry S. Desser; R. Brooke Jeffrey

Tissue harmonic imaging (THI) is a new gray-scale sonographic technique that improves image clarity. Harmonics form within the insonated tissue as a consequence of nonlinear sound propagation. Imaging with endogenously formed harmonics means that the distorting layer of the body wall is traversed only once by the harmonic beam--during echo reception. Both image contrast and lateral resolution are improved in harmonic mode compared with conventional (fundamental mode) sonography. This article summarizes the physics and various implementations of harmonic imaging mode, and reviews the clinical applications that have emerged to date.


Journal of Ultrasound in Medicine | 2002

Sonography in primary hyperparathyroidism: review with emphasis on scanning technique.

Scott B. Reeder; Terry S. Desser; Ronald J. Weigel; R. Brooke Jeffrey

Objective. To review the sonographic features and focused sonographic scanning techniques that may assist in the preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism. Methods. The sonographic findings were reviewed in 54 of 58 consecutive patients with pathologically proven parathyroid adenomas. A systematic scanning approach including real‐time gray scale, color and power Doppler, and graded compression gray scale imaging was used in all patients. Results. Fifty‐four (93%) of 58 proven adenomas were correctly identified by sonography. Gray scale imaging alone was sufficient for identifying 26 (100%) of 26 large (≥1‐cm) and 3 (11%) of 25 small (<1‐cm) parathyroid adenomas. However, for 25 (89%) of 28 small adenomas, a combination of color and power Doppler and graded compression real‐time gray scale imaging was required for sonographic localization and identification. Conclusions. Knowledge of typical locations and characteristic imaging features, as well as a systematic scanning approach, can result in accurate preoperative sonographic localization of parathyroid adenomas.


Journal of The American College of Radiology | 2018

ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee

Franklin N. Tessler; William D. Middleton; Edward G. Grant; Jenny K. Hoang; Lincoln L. Berland; Sharlene A. Teefey; John J. Cronan; Michael D. Beland; Terry S. Desser; Mary C. Frates; Lynwood Hammers; Ulrike M. Hamper; Jill E. Langer; Carl C. Reading; Leslie M. Scoutt; A. Thomas Stavros

Thyroid nodules are a frequent finding on neck sonography. Most nodules are benign; therefore, many nodules are biopsied to identify the small number that are malignant or require surgery for a definitive diagnosis. Since 2009, many professional societies and investigators have proposed ultrasound-based risk stratification systems to identify nodules that warrant biopsy or sonographic follow-up. Because some of these systems were founded on the BI-RADS® classification that is widely used in breast imaging, their authors chose to apply the acronym TI-RADS, for Thyroid Imaging, Reporting and Data System. In 2012, the ACR convened committees to (1) provide recommendations for reporting incidental thyroid nodules, (2) develop a set of standard terms (lexicon) for ultrasound reporting, and (3) propose a TI-RADS on the basis of the lexicon. The committees published the results of the first two efforts in 2015. In this article, the authors present the ACR TI-RADS Committees recommendations, which provide guidance regarding management of thyroid nodules on the basis of their ultrasound appearance. The authors also describe the committees future directions.


American Journal of Roentgenology | 2010

Hashimoto Thyroiditis: Part 1, Sonographic Analysis of the Nodular Form of Hashimoto Thyroiditis

Lauren Anderson; William D. Middleton; Sharlene A. Teefey; Carl C. Reading; Jill E. Langer; Terry S. Desser; Margaret M. Szabunio; Charles F. Hildebolt; Susan J. Mandel; John J. Cronan

OBJECTIVE The purpose of this article is to analyze the sonographic appearance of nodular Hashimoto thyroiditis. SUBJECTS AND METHODS As part of an ongoing multiinstitutional study, patients who underwent ultrasound examination and fine-needle aspiration of one or more thyroid nodules were analyzed for multiple predetermined sonographic features. Patients completed a questionnaire, including information about thyroid function and thyroid medication. Patients (n = 61) with fine-needle aspiration cytologic results consistent with nodular Hashimoto thyroiditis (n = 64) were included in the study. RESULTS The mean (+/- SD) diameter of nodular Hashimoto thyroiditis was 15 +/- 7.33 mm. Nodular Hashimoto thyroiditis occurred as a solitary nodule in 36% (23/64) of cases and in the setting of five or more nodules in 23% (15/64) of cases. Fifty-five percent (35/64) of the cases of nodular Hashimoto thyroiditis occurred within a sonographic background of diffuse Hashimoto thyroiditis, and 45% (29/64) of cases occurred within normal thyroid parenchyma. The sonographic appearance was extremely variable. It was most commonly solid (69% [42/61] of cases) and hypoechoic (47% [27/58] of cases). Twenty percent (13/64) of nodules had calcifications (seven with nonspecific bright reflectors, four with macrocalcifications, and three eggshell), and 5% (3/64) of nodules had colloid. Twenty-seven percent (17/64) of nodules had a hypoechoic halo. The margins were well defined in 60% (36/60) and ill defined in 40% (24/60) of nodules. On Doppler analysis, 35% (22/62) of nodules were hypervascular, 42% (26/62) were isovascular or hypovascular, and 23% (14/62) were avascular. CONCLUSION The sonographic features and vascularity of nodular Hashimoto thyroiditis were extremely variable.


Bioconjugate Chemistry | 1999

Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

David Lee Ladd; Robert Hollister; Xin Peng; Donna Wei; Gang Wu; Daniel J. Delecki; Robert A. Snow; John L. Toner; Kenneth E. Kellar; Jennifer Eck; Vinay Chandrakant Desai; Gemma Raymond; Lewis B. Kinter; Terry S. Desser; Daniel L. Rubin

We have synthesized and evaluated five series of polymeric gadolinium chelates which are of interest as potential MRI blood pool contrast agents. The polymers were designed so that important physical properties including molecular weight, relaxivity, metal content, viscosity, and chelate stability could be varied. We have shown that, by selecting polymers of the appropriate MW, extended blood pool retention can be achieved. In addition, relaxivity can be manipulated by changing the polymer rigidity, metal content affected by monomer selection, viscosity by polymer shape, and chelate stability by chelator selection.


Medical Physics | 2004

Automatic detection and classification of hypodense hepatic lesions on contrast‐enhanced venous‐phase CT

Michel Bilello; Salih Burak Gokturk; Terry S. Desser; Sandy Napel; R. Brooke Jeffrey; Christopher F. Beaulieu

The objective of this work was to develop and validate algorithms for detection and classification of hypodense hepatic lesions, specifically cysts, hemangiomas, and metastases from CT scans in the portal venous phase of enhancement. Fifty-six CT sections from 51 patients were used as representative of common hypodense liver lesions, including 22 simple cysts, 11 hemangiomas, 22 metastases, and 1 image containing both a cyst and a hemangioma. The detection algorithm uses intensity-based histogram methods to find central lesions, followed by liver contour refinement to identify peripheral lesions. The classification algorithm operates on the focal lesions identified during detection, and includes shape-based segmentation, edge pixel weighting, and lesion texture filtering. Support vector machines are then used to perform a pair-wise lesion classification. For the detection algorithm, 80% lesion sensitivity was achieved at approximately 0.3 false positives (FP) per slice for central lesions, and 0.5 FP per slice for peripheral lesions, giving a total of 0.8 FP per section. For 90% sensitivity, the total number of FP rises to about 2.2 per section. The pair-wise classification yielded good discrimination between cysts and metastases (at 95% sensitivity for detection of metastases, only about 5% of cysts are incorrectly classified as metastases), perfect discrimination between hemangiomas and cysts, and was least accurate in discriminating between hemangiomas and metastases (at 90% sensitivity for detection of hemangiomas, about 28% of metastases were incorrectly classified as hemangiomas). Initial implementations of our algorithms are promising for automating liver lesion detection and classification.


Magnetic Resonance Imaging | 1990

Scaphoid fractures and Kienbock's disease of the lunate: MR imaging with histopathologic correlation

Terry S. Desser; Shirley McCarthy; Thomas Trumble

Thirteen patients with scaphoid fractures and four patients with Kienbocks disease of the lunate underwent magnetic resonance imaging (MRI) prior to surgery. A total of 28 specimens had MR-histologic correlation. Biopsy specimens obtained by curettage provided pathologic correlation. MRI proved accurate in prospective evaluation of bone viability for both scaphoid fractures and Kienbocks disease. Normal marrow signal was shown to correlate with the presence of osteoid and osteocytes on light microscopy and a surface layer of fluorescence reflecting tetracycline uptake in viable bone. Decreased marrow signal corresponded to non-viable trabeculae with scant osteoid, without osteocytes and no tetracycline labeling. By virtue of its accurate identification of avascular necrosis, MRI may prove valuable in predicting prognosis for patients with scaphoid fractures and Kienbocks disease of the lunate.

Collaboration


Dive into the Terry S. Desser's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jill E. Langer

Hospital of the University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Sharlene A. Teefey

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

William D. Middleton

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge